Moneycontrol PRO

Chemo-Pharma Laboratories

Followers

0
0
0
0
.
0
0
2
2
1
1
5.65 (4.94%)

As on 01 Oct, 2025 | 16:01

Open Trading A/c
Day Range
112.25
120.00
LH
52 Week Range
59.58
154.00
LH
Volume
* i
Bid / Ask
427.00
0.00 / 0.00

Chemo-Pharma Laboratories Announcements

Change of name of Company from Chemo Pharma Laboratories Limited to Starsource Multitrade Limited.

01 Oct, 2025 | 04:56pm • Source: BSE

Intimation of Closure of Trading Window

25 Sep, 2025 | 06:29pm • Source: BSE

Regularizing appointments of Directors and Appointment of Statutory Auditor & Secretarial Auditor in AGM.

25 Sep, 2025 | 06:27pm • Source: BSE

AGM Outcome with Scrutinizer Report.

25 Sep, 2025 | 06:19pm • Source: BSE

In compliance with the provisions of Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, a summary of the proceedings...

24 Sep, 2025 | 05:39pm • Source: BSE

The Company has filed an Application on 10th September, 2025 to BSE Limited for approval of reclassification from Promoter Group Shareholder Category to Public Shareholder...

23 Sep, 2025 | 11:39am • Source: BSE

Appointment of Mr. Aditya Agarwal as new Company Secretary & Compliance Officer of the Company and resignation of Ms. Bhawna Rajput from the post of...

12 Sep, 2025 | 04:04pm • Source: BSE

Submission of notice for attention of Equity Shareholders of the Company in respect of information regarding 83rd Annual General Meeting to be held on 24th...

29 Aug, 2025 | 06:44pm • Source: BSE

Notice of 83rd AGM scheduled on 24th September, 2025

28 Aug, 2025 | 07:22pm • Source: BSE

Annual Report FY 2024-25

28 Aug, 2025 | 07:04pm • Source: BSE

Submission of Newspaper Advertisements for attention of Equity Shareholders of the Company in respect of information regarding 83rd Annual General Meeting to be held on...

27 Aug, 2025 | 01:22pm • Source: BSE

Intimation of Book Closure to the Regulation 42(2) to 42(4) of SEBI (LODR) Regulations, 2015.

12 Aug, 2025 | 07:17pm • Source: BSE

Approval of Un-Audited Financial Results of the Company for the Quarter ended June 30, 2025 along with the Limited Review Report thereon.

12 Aug, 2025 | 07:09pm • Source: BSE

Board of Directors of the Company at their meeting held on Tuesday, August 12, 2025 , have discussed the following matters:1. Approved the Un-Audited Financial...

12 Aug, 2025 | 07:04pm • Source: BSE

Intimation of Receipt of Request For Reclassification From ''Promoter Group Shareholder'' to ''Public Shareholder'' under Regulation 31A of the SEBI (LODR) Regulations, 2015

11 Aug, 2025 | 06:06pm • Source: BSE

Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider...

05 Aug, 2025 | 12:16pm • Source: BSE

Outcome of Board Meeting. INTIMATION OF APPOINTMENT OF STATUTORY AUDITOR. 1. Resignation of Statutory Auditor: The Board of Directors noted and accepted the resignation...

31 Jul, 2025 | 10:37am • Source: BSE

Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider...

28 Jul, 2025 | 11:40am • Source: BSE

Resignation of Statutory Auditors

24 Jul, 2025 | 07:10pm • Source: BSE

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Atibha Agriseeds Pvt Ltd

21 Jul, 2025 | 02:38pm • Source: BSE